Transchem Ltd (TRANSCHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 538955,
    "name": "Transchem",
    "stock_name": "Transchem",
    "full_name": "Transchem Ltd",
    "name_url": "stocks-analysis/transchem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "356.00",
    "chg": 1.2,
    "chgp": "0.34%",
    "dir": 1,
    "prev_price": "354.80",
    "mcapval": "434.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500422,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE019B01010",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "12:53 PM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": "4.07 k",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transchem-538955-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Transchem Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-transchem-ltd-latest-results-good-or-bad-3978373",
        "imagepath": "",
        "date": "2026-05-06 19:15:24",
        "description": "Transchem Ltd's latest financial results for Q4 FY26 reveal significant operational challenges. The company reported net sales of ₹0.00 crore, marking a complete year-on-year decline of 100.00% from ₹2.42 crores in Q4 FY25. This consistent absence of revenue over three consecutive quarters suggests a fundamental shift away from its core pharmaceutical manufacturing operations.\n\nIn contrast, the net profit for Q4 FY26 was ₹2.09 crores, which represents a year-on-year increase of 186.30% from ₹0.73 crores in the same quarter last year. This increase is largely attributed to a substantial rise in other income, which reached ₹3.70 crores, indicating that the company's profitability is now heavily reliant on non-operating income rather than its core business activities.\n\nThe operating profit before depreciation, interest, and tax (excluding other income) was negative ₹1.31 crores, indicating that the company is ..."
      },
      {
        "title": "Transchem Ltd Q4 FY26: Revenue Collapse Exposes Troubling Business Model Shift",
        "link": "https://www.marketsmojo.com/news/result-analysis/transchem-ltd-q4-fy26-revenue-collapse-exposes-troubling-business-model-shift-3977823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/Transchem_quaterlyResult_3977823.png",
        "date": "2026-05-06 09:49:04",
        "description": "Transchem Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹213.00 crores, reported deeply concerning results for Q4 FY26, with net sales collapsing to absolute zero and the company now entirely dependent on non-operating income for survival. Despite posting a net profit of ₹2.09 crores in the March 2026 quarter, the complete absence of revenue raises serious questions about the company's core business viability and long-term sustainability."
      },
      {
        "title": "When is the next results date for Transchem Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-transchem-ltd-3969173",
        "imagepath": "",
        "date": "2026-04-29 23:16:09",
        "description": "The next results date for Transchem Ltd is scheduled for 05 May 2026...."
      },
      {
        "title": "Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-downgraded-to-strong-sell-amid-weak-financials-and-mixed-technical-signals-3967485",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TranschemLtd_mojoScore_3967485.png",
        "date": "2026-04-29 08:02:26",
        "description": "Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 28 Apr 2026. This shift reflects a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and nuanced technical signals, despite the company’s impressive long-term stock returns."
      },
      {
        "title": "Transchem Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-sell-3966330",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TranschemLtd_mojoScore_3966330.png",
        "date": "2026-04-28 10:10:55",
        "description": "Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      }
    ],
    "total": 181,
    "sid": "538955",
    "stock_news_url": "https://www.marketsmojo.com/news/transchem-538955"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Jul-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "05-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bakkt Opco Holdings LLC",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "05-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pishu V Chainani",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Transchem Ltd latest results good or bad?

2026-05-06 19:15:24

Transchem Ltd's latest financial results for Q4 FY26 reveal significant operational challenges. The company reported net sales of ₹0.00 crore, marking a complete year-on-year decline of 100.00% from ₹2.42 crores in Q4 FY25. This consistent absence of revenue over three consecutive quarters suggests a fundamental shift away from its core pharmaceutical manufacturing operations. In contrast, the net profit for Q4 FY26 was ₹2.09 crores, which represents a year-on-year increase of 186.30% from ₹0.73 crores in the same quarter last year. This increase is largely attributed to a substantial rise in other income, which reached ₹3.70 crores, indicating that the company's profitability is now heavily reliant on non-operating income rather than its core business activities. The operating profit before depreciation, interest, and tax (excluding other income) was negative ₹1.31 crores, indicating that the company is ...

Read full news article

Transchem Ltd Q4 FY26: Revenue Collapse Exposes Troubling Business Model Shift

2026-05-06 09:49:04

Transchem Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹213.00 crores, reported deeply concerning results for Q4 FY26, with net sales collapsing to absolute zero and the company now entirely dependent on non-operating income for survival. Despite posting a net profit of ₹2.09 crores in the March 2026 quarter, the complete absence of revenue raises serious questions about the company's core business viability and long-term sustainability.

Read full news article

When is the next results date for Transchem Ltd?

2026-04-29 23:16:09

The next results date for Transchem Ltd is scheduled for 05 May 2026....

Read full news article

Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals

2026-04-29 08:02:26

Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 28 Apr 2026. This shift reflects a complex interplay of deteriorating financial fundamentals, challenging valuation metrics, and nuanced technical signals, despite the company’s impressive long-term stock returns.

Read full news article

Transchem Ltd is Rated Sell

2026-04-28 10:10:55

Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Read full news article

View All News